A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacological treatment of insulin resistance syndrome

MLA

Maraldi, N. M., et al. A Pathogenic Mechanism Leading to Partial Lipodistrophy and Prospects for Pharmacological Treatment of Insulin Resistance Syndrome. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..205783b667368ab053d77941188729d3&authtype=sso&custid=ns315887. Accessed 11 Nov. 2024.

APA

Maraldi, N. M., Capanni, C., Mattioli, E., Columbaro, M., Stefano Squarzoni, Parnaik, W. K., Wehnert, M., & Lattanzi, G. (n.d.). A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacological treatment of insulin resistance syndrome.

Chicago

Maraldi, N. M., C. Capanni, E. Mattioli, M. Columbaro, Stefano Squarzoni, W. K. Parnaik, M. Wehnert, and G. Lattanzi. 2024. “A Pathogenic Mechanism Leading to Partial Lipodistrophy and Prospects for Pharmacological Treatment of Insulin Resistance Syndrome.” Accessed November 11. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..205783b667368ab053d77941188729d3&authtype=sso&custid=ns315887.